Grant RadarWorldwide funding
Log inGet started
Back to Grants
Health Open for ApplicationsPAR-25-095

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

National Institutes of Health opportunity PAR-25-095

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthPAR-25-095Grants.gov
Related Grants
Health● Open
DoW Rare Cancers Idea Development Award
Varies
18 Nov 2026(47d)
Health● Open
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
Varies
07 Jan 2027(97d)
Health● Open
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
Varies
15 Oct 2027(378d)
HealthUpcoming
Exposomic Contributions to ADRD Pathology and Resilience
Varies
Funding Amount
Varies
USD
Application Deadline
6 November 2026
35 days remaining
Opens: 18 Nov 2024
Apply Now
Programme Details
Programme Code
PAR-25-095